By Amy Norton
WEDNESDAY, July one, 2020 (HealthDay News)
Scientists are reporting an early phase towards an HIV drug that could potentially be taken only a couple of times per year.
A single injection of the experimental drug, identified as lenacapavir, was equipped to lower blood ranges of HIV in a tiny group of patients. And it was able of sustaining active ranges in the blood for a lot more than six months.
It all raises the chance of one day owning an HIV procedure that only requirements to be taken two times a year.
The latest procedure regimens for HIV — mixtures of oral medicines normally identified as “cocktails” — typically do the job quite well, reported research co-creator Dr. Martin Rhee.
“But patients normally say that about time, taking each day pills can be a stress,” reported Rhee, director of clinical research for Gilead Sciences, Inc.